Drug
[68Ga]Ga-FAPI-46 PET/CT
[68Ga]Ga-FAPI-46 PET/CT is a pharmaceutical drug with 3 clinical trials. Currently 3 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(100%)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_2
2
67%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 22 (66.7%)
N/A1 (33.3%)
Trials by Status
recruiting3100%
Recent Activity
3 active trials
Showing 3 of 3
recruitingphase_2
[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas
NCT06794372
recruitingphase_2
The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
NCT06790082
recruitingnot_applicable
[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer
NCT05957250
Clinical Trials (3)
Showing 3 of 3 trials
NCT06794372Phase 2
[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas
NCT06790082Phase 2
The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
NCT05957250Not Applicable
[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3